NEW YORK, May 22, 2017 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Amgen Inc. (“Amgen” or the “Company”) (NASDAQ: AMGN). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980….
May 23, 2017 at 02:19AM
from
No comments:
Post a Comment